...
首页> 外文期刊>Medicine. >Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
【24h】

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.

机译:成人血液系统恶性肿瘤和人类干细胞移植受者的呼吸道病毒感染:在主要癌症中心的回顾性研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Community respiratory viruses (CRVs) have been recognized as a potential cause of pneumonia and death among hematopoietic stem cell transplantation (HSCT) recipients and patients with hematologic malignancies. We reviewed the Microbiology Laboratory records dated from July 1, 2000, to June 30, 2002, to identify patients who had respiratory specimens positive for influenza, parainfluenza, respiratory syncytial virus, or picornavirus. We identified 343 infections among patients with underlying hematologic malignancies and HSCT. We collected data on type of disease, age, sex, type of infection, neutrophil and lymphocyte counts, therapy, and outcome. Influenza, parainfluenza, and respiratory syncytial virus accounted for most cases and were approximately equal in frequency. Most infections occurred predominantly among recipients of allogeneic transplants. Infection progressed to pneumonia in 119 patients (35%) and occurred with similar frequency for the 3 viruses. Patients at greatest risk for developing pneumonia included those with leukemia, those aged more than 65 years, and those with severe neutropenia or lymphopenia. Lack of respiratory syncytial virus-directed antiviral therapy (p=0.025) and age (p=0.042) were associated with development of respiratory syncytial virus pneumonia, and an absolute lymphocyte count
机译:社区呼吸道病毒(CRV)已被认为是造血干细胞移植(HSCT)接受者和血液系统恶性肿瘤患者中肺炎和死亡的潜在原因。我们回顾了微生物实验室从2000年7月1日至2002年6月30日的记录,以鉴定呼吸道标本对流感,副流感,呼吸道合胞病毒或小核糖核酸病毒呈阳性的患者。我们在潜在的血液系统恶性肿瘤和HSCT患者中发现了343例感染。我们收集了有关疾病类型,年龄,性别,感染类型,中性粒细胞和淋巴细胞计数,治疗方法和结果的数据。流感,副流感和呼吸道合胞病毒占大多数病例,发生频率大致相等。大多数感染主要发生在同种异体移植的接受者中。 119名患者(35%)的感染进展为肺炎,三种病毒的发生频率相似。患肺炎风险最高的患者包括白血病患者,65岁以上的患者以及严重的中性粒细胞减少或淋巴细胞减少的患者。缺乏呼吸道合胞病毒指导的抗病毒治疗(p = 0.025)和年龄(p = 0.042)与呼吸道合胞病毒性肺炎的发展有关,并且绝对淋巴细胞计数<或= 200细胞/ mL(p = 0.049)随着流感性肺炎的发展。 CRV肺炎的总死亡率为15%。致命结果的唯一独立预测因子是流感性肺炎患者的绝对淋巴细胞计数<或= 200细胞/ mL(p = 0.03)。应考虑将HSCT接受者和因CRV而发展为上呼吸道感染的血液系统恶性肿瘤患者考虑抗病毒治疗经证实有效的疗法可减少肺炎和死亡的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号